Crossmark

Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes

Crossref DOI link: https://doi.org/10.1007/s10238-018-0519-0

Published Online: 2018-07-17

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xia

Zheng, Peilin

Huang, Gan

Yang, Lin

Zhou, Zhiguang https://orcid.org/0000-0002-0374-1838
Funding

Funding for this research was provided by:

the National Key R&D Program of China (2016YFC1305000)

the National Key R&D Program of China (2016YFC1305001)

the National Science and Technology Infrastructure Program (2015BAI12B13)

the National Natural Science Foundation of China (81170725)

the National Natural Science Foundation of China (81070627)

the National Natural Science Foundation of China (81500600)

the National Natural Science Foundation of China (8146168031)
License Information

Text and Data Mining valid from 2018-07-17
More Information

Article History

Received: 14 May 2018

Accepted: 8 July 2018

First Online: 17 July 2018

Compliance with ethical standards

:

: The authors declare no conflicts of interest.